EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, BIOCQ: Biocept Inc

07 Nov 2025
LAST:

0.0001

CHANGE:
 0.00		OPEN:
0.0001		HIGH:
0.0001		ASK:
0.0000		VOLUME:
20.1K
CHG(%):
0.00		PREV:
0.0001		LOW:
0.0001		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 250.00010.00010.00010.000120.1K
06 Nov 250.00010.00010.00010.00011.6K
05 Nov 250.00010.00010.00010.0001400
03 Nov 250.00010.00010.00010.000120.3K
31 Oct 250.00010.00010.00010.00011.2K
28 Oct 250.00010.00010.00010.0001100
27 Oct 250.00010.00010.00010.00011.1K

COMPANY PROFILE

Name:Biocept Inc
About:Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, radiation oncologists, urologists, pulmonologists, pathologists, and other physicians; and clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California. On October 13, 2023, Biocept, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Sector:Healthcare
Address:9955 Mesa Rim Road, San Diego, CA, United States, 92121
Website:https://biocept.com
CIK:0001044378
ISIN:US09072V6002
FIGI:BBG000RRRD66

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.000.0%
MA10:0.000.0%
MA20:0.000.0%
MA50:0.002,800.0%
MA100:0.001,600.0%
Week High:0.000.0%
Week Low:0.000.0%
Month High:0.000.0%
Month Low:0.00